(“Type 2 Diabetes Mellitus”) AND (“SGLT-2 inhibitors”) AND (“GLP-1 receptor agonists”) AND (“Randomized Controlled Trial”). The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.